Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Authors: Mehmet Soy 1, Gökhan Keser 2, Pamir Atagündüz 3, Fehmi Tabak 4, Işık Atagündüz 5, Servet Kayhan COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes only mild symptoms in the majority of the cases,…[...]

Read More

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

Authors: Joanna Hellmuth 1 2, T Allen Barnett 3, Breton M Asken 4, J Daniel Kelly 5, Leonel Torres 6, Melanie L Stephens 4 7, Bryan Greenhouse 6, Jeffrey N Martin 5, Felicia C Chow 7 8, Steven G Deeks 9, Meredith Greene 10, Bruce L Miller 4 7, Wesley Annan 4 7, Timothy J Henrich 6, Michael J Peluso 9 As cases of…[...]

Read More

SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

Syndrome coronavirus 2 (SARS-CoV-2) pandemic is causing a second outbreak significantly delaying the hope for the virus’ complete eradication. In the absence of effective vaccines, we need effective treatments with…[...]

Read More